Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer
NCT00477100
This study is recruiting at 8 US sites in 4 states, according to its ClinicalTrials.gov record last updated .
Summary
This trial studies the biospecimen and medical data collection in creating a research tissue registry in patients with inflammatory or invasive breast cancer. Collecting medical data and storing samples of blood, tissue, and stool from patients with inflammatory breast cancer to study in the laboratory may help doctors find better ways to treat and study inflammatory breast cancer in the future.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Inflammatory Breast Carcinoma
- Invasive Breast Carcinoma
- Second Primary Malignant Neoplasm
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- M.D. Anderson Cancer Center
- Last updated on ClinicalTrials.gov
- October 6, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Arizona · 1
- Banner - MD Anderson Cancer Center · Gilbert, AZ
Colorado · 1
- Banner - MD Anderson Cancer Center - Northern Colorado · Greeley, CO
Florida · 1
- Baptist - MD Anderson Cancer Center · Jacksonville, FL
Texas · 5
- M D Anderson Cancer Center · Houston, TX
- MD Anderson in Katy · Houston, TX
- MD Anderson League City · Nassau Bay, TX
- MD Anderson in Sugar Land · Sugar Land, TX
- MD Anderson in The Woodlands · The Woodlands, TX
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.